stockrowApnimed, Inc. (APMD) vs ArriVent BioPharma, Inc. (AVBP)
- Apnimed, Inc. APMD 15.08 +6.50%
- ArriVent BioPharma, Inc. AVBP 13.62 +11.37%
Apnimed, Inc. and ArriVent BioPharma, Inc. are both Biotechnology companies. Apnimed, Inc. and ArriVent BioPharma, Inc. are of similar size ($603.0M and $589.5M). ArriVent BioPharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Apnimed, Inc. trades at 0.8×. Apnimed, Inc. has the higher net margin (81.6% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Apnimed, Inc. leads on 8 and ArriVent BioPharma, Inc. on 3.
Valuation
Profitability
| Metric | APMD | AVBP | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.53% | — | 68.51% |
| Operating margin | 19.88% | 0.00% | 0.00% |
| Net margin | 81.56% | 0.00% | 0.00% |
| Free cash flow margin | (71.50%) | 0.00% | 0.00% |
| Return on equity | 0.00% | (53.10%) | (51.96%) |
| Return on assets | 0.00% | (49.30%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack